Results 221 to 230 of about 15,268,350 (380)

McSwan type V appendiceal intussusception and acute appendicitis coexistence in a 4-year-old child: a case report and review of the literature. [PDF]

J Surg Case Rep
Shihab R, Abdallah HO, Nafaa A, Abdallah YN, Kittaneh M.   +4 more
europepmc   +1 more source

Enzymically Active and Inactive Melanocyte Populations and Ultraviolet Irradiation: Combined Dopa-Premelanin Reaction and Electron Microscopy**From the Departments of Dermatology, Wayne State University School of Medicine, Detroit, and Veterans Administration Hospital, Dearborn, Michigan, U.S.A.

, 1967
Yutaka Mishima, Sheldon Widlan
openalex   +1 more source

Biomarkers and Precision Medicine: State of the Art.

Critical care clinics, 2020
Aartik Sarma, C. Calfee, L. Ware
semanticscholar   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

How the National Library of Medicine should evolve in an era of artificial intelligence. [PDF]

J Am Med Inform Assoc
Lenert LA.
europepmc   +1 more source

Medicine in the United States [PDF]

BMJ, 1947
openaire   +3 more sources

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Corrigendum to 'Guillain-Barré syndrome in pregnancy: a case report and review of the literature' [AJOG Global Reports, Volume 4, Issue 4, November 2024, 100396]. [PDF]

AJOG Glob Rep
Iliadi-Tulbure C, Cemortan M, Jubirca S, Cospormac V, Bubulici C, Vicol MM.   +5 more
europepmc   +1 more source